Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction
M Rosenquvist,
MA Lee,
L Moulinier,
MJ Springer,
JA Abbott,
J Wu,
JJ Langberg,
JC Griffin,
and
MM Scheinman
Department of Medicine, University of California, San Francisco.
The long-term follow-up study (41 +/- 23 months) of 47 patients undergoing direct current ablation because of drug-resistant supraventricular arrhythmias is reported. Significant early complications occurred in four patients and included hypotension, pericarditis, nonsustained polymorphic ventricular tachycardia and one sudden death. In 42 patients (86%), complete atrioventricular (AV) block was initially achieved. During the follow-up period, AV conduction resumed in 2 of these 42 patients. Of the seven patients in whom ablation was unsuccessful, two developed late complete AV block and three had symptomatic improvement. An improved activity level was reported among 83% of the patients with successful ablation. Health care utilization manifest as the number of hospital admissions per year before and after ablation decreased significantly after ablation (2.4 +/- 2.0 versus 0.3 +/- 0.5, p less than 0.001). Echocardiographic evaluation in five patients with a depressed left ventricular ejection fraction (27 +/- 7%) before ablation showed a significant increase (45 +/- 14%, p less than 0.05) after an average follow-up period of 31 months. New onset of congestive heart failure occurred after ablation in four patients, of whom two had no structural heart disease. The total mortality rate, including the one patient with sudden death, was 17% and was significantly higher among patients with underlying structural heart disease. Transcatheter direct current ablation is an effective treatment in patients with drug-resistant supraventricular tachycardia, providing a beneficial long-term outcome including an improved quality of life and a decrease in health care utilization.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:

|
 |

|
 |
 
M. Brignole, M. Gammage, E. Puggioni, P. Alboni, A. Raviele, R. Sutton, P. Vardas, M.G. Bongiorni, L. Bergfeldt, C. Menozzi, et al.
Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation
Eur. Heart J.,
April 1, 2005;
26(7):
712 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Nerheim, S. Birger-Botkin, L. Piracha, and B. Olshansky
Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia
Circulation,
July 20, 2004;
110(3):
247 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D.M Engelmann and S. Pehrson
Quality of life in nonpharmacologic treatment of atrial fibrillation
Eur. Heart J.,
August 1, 2003;
24(15):
1387 - 1400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole
A novel use of cardiac pacing to improve cardiac function, quality of life and (hopefully) survival in patients with heart failure and permanent atrial fibrillation
Eur. Heart J.,
November 2, 2002;
23(22):
1732 - 1736.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Howes, M. C. Reid, C. Brandt, B. Ruo, M. W. Yerkey, B. Prasad, C. Lin, P. Peduzzi, and M. D. Ezekowitz
Exercise Tolerance and Quality of Life in Elderly Patients with Chronic Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2001;
6(1):
23 - 29.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T Levy, S Walker, M Mason, P Spurrell, S Rex, S Brant, and V Paul
Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study
Heart,
February 1, 2001;
85(2):
171 - 178.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Brignole and M. Gammage
A novel use of cardiac pacing to improve cardiac function in patients with heart failure and permanent atrial fibrillation
Europace,
January 1, 2001;
3(2):
150 - 152.
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Hamdan, R. L. Page, C. J. Sheehan, J. D. Zagrodzky, S. L. Wasmund, K. Ramaswamy, J. A. Joglar, and M. L. Smith
Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation
J. Am. Coll. Cardiol.,
July 1, 2000;
36(1):
151 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Luderitz and W. Jung
Quality of Life in Patients With Atrial Fibrillation
Arch Intern Med,
June 26, 2000;
160(12):
1749 - 1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Scheinman
Mechanisms of atrial fibrillation: is a cure at hand?
J. Am. Coll. Cardiol.,
May 1, 2000;
35(6):
1687 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Gasparini, M Mantica, M Brignole, L Gianfranchi, C Menozzi, F Pizzetti, G Magenta, P Delise, A Proclemer, S Tognarin, et al.
Thromboembolism after atrioventricular node ablation and pacing: long term follow up
Heart,
October 1, 1999;
82(4):
494 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Marshall, Z. I. Harris, M. J. Griffith, R. L. Holder, and M. D. Gammage
Prospective Randomized Study of Ablation and Pacing Versus Medical Therapy for Paroxysmal Atrial Fibrillation : Effects of Pacing Mode and Mode-Switch Algorithm
Circulation,
March 30, 1999;
99(12):
1587 - 1592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Levy
Atrioventricular junctional ablation and pacing for paroxysmal atrial fibrillation: the Barcelona recommendations
Europace,
January 1, 1999;
1(1):
2 - 4.
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole, M. Gammage, L. Jordaens, R. Sutton, and on behalf of the Barcelona Discussion Group
Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation
Europace,
January 1, 1999;
1(1):
8 - 13.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Marshall and M. J. Griffith
Ablation of the atrioventricular junction: Technique, acute and long-term results in 115 consecutive patients
Europace,
January 1, 1999;
1(1):
26 - 29.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Scheinman
Atrial Fibrillation and Congestive Heart Failure : The Intersection of Two Common Diseases
Circulation,
September 8, 1998;
98(10):
941 - 942.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brignole, C. Menozzi, L. Gianfranchi, G. Musso, R. Mureddu, N. Bottoni, and G. Lolli
Assessment of Atrioventricular Junction Ablation and VVIR Pacemaker Versus Pharmacological Treatment in Patients With Heart Failure and Chronic Atrial Fibrillation : A Randomized, Controlled Study
Circulation,
September 8, 1998;
98(10):
953 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M BRIGNOLE
Ablate and pace: a pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs
Heart,
June 1, 1998;
79(6):
531 - 533.
[Full Text]
|
 |
|

|
 |

|
 |
 
H J Marshall, Z I Harris, M J Griffith, and M D Gammage
Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation
Heart,
June 1, 1998;
79(6):
543 - 547.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. D. Krahn, G. J. Klein, R. Yee, M. N. Basta, and J. K. Lee
Progressive Anterior Ablation in the Coronary Sinus Region : Evidence to Support the Presence of a `Slow Pathway' Input in Normal Patients?
Circulation,
November 18, 1997;
96(10):
3477 - 3483.
[Abstract]
[Full Text]
|
 |
|
|